iAnthus Provides Update to Litigation Claim

Core Viewpoint - iAnthus Capital Holdings has reached a settlement agreement with Ninth Square Capital Corporation regarding ongoing legal proceedings, involving the issuance of 5 million common shares at a deemed price of C$0.01 per share [2][3]. Group 1: Legal Proceedings - Ninth Square filed a statement of claim against iAnthus and its subsidiaries in August 2019, alleging oppressive conduct related to an arrangement with MPX Bioceutical Corporation [1]. - The settlement agreement does not include any admission of wrongdoing or liability by iAnthus or its subsidiaries, and the company continues to contest the allegations [3]. Group 2: Settlement Details - The settlement involves the issuance of 5,000,000 common shares to Ninth Square, valued at C$0.01 per share [2]. - The shares will be issued under a prospectus exemption in Canada and will not be registered under the U.S. Securities Act, making them "restricted securities" [4]. Group 3: Company Overview - iAnthus operates licensed cannabis cultivation, processing, and dispensary facilities across the United States [5].